VenoStent
Absorbable wrap for blood vessels
About VenoStent
There are 10 million dialysis and bypass surgeries per year, but half of them fail. VenoStent saves lives with a wrap that goes around blood vessels during surgery so they don't fail.
Company details
Funding
Total raised
$30.6M
Last stage
Series A
Investors
Founders
Geoffrey Lucks
Co-founder & COO of pivotal trial-stage therapeutic medical device company developing bioabsorbable wraps to improve vascular surgery. Vandy MBA, UPenn Masters of Bioethics, UW-Madison UG Interested in tech and culture. Reading: the classics, religion, economics, finance, politics, philosophy, history, social sciences, etc. Born mellow and everywhere harshed.
LinkedInTimothy (Tim) Boire
PhD in Biomedical Engineering from Vanderbilt University; inventor of VenoStent's SelfWrap shape memory polymer technology; previously a Research Associate at Genzyme Corporation.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.